Usmle Step1

Front 1

epinephrine

Back 1

increase hr,increase sbp,decrease dbp

Front 2

succinylcholine cause

Back 2

fasciculation

Front 3

fasciculation

Back 3

繊維束性攣縮

Front 4

hemolytic anemia

Back 4

溶血性貧血

Front 5

erythroid

Back 5

赤血球の

Front 6

prochlorperazine

Back 6

antiemetic agent
act as D2 receptor

Front 7

buspirone

Back 7

nonbenzodiazepine anxiolytic
partial agonist at 5-HT receptor

Front 8

antineoplastic agent

Back 8

抗癌剤

Front 9

cyclophosphamide is notable for

Back 9

hemorrhagic cystitis

Front 10

cyctitis

Back 10

膀胱炎

Front 11

bleomycin

Back 11

plumonary toxicity

Front 12

cisplatin

Back 12

nephrotoxicity&ototoxicity

Front 13

doxorubicin(adriamycin)

Back 13

cardiotoxicity

Front 14

vincristine

Back 14

dose limiting neurotoxicity

Front 15

CL=
t1/2=

Back 15

CL=k*Vd
t1/2=0.7/k

Front 16

flumazenil

Back 16

benzodiazepine antagonist

Front 17

epinephrine

Back 17

increase hr
increase SBP,decreaseDBP

Front 18

norepinephrine

Back 18

decrease hr
increase SBP,DBP

Front 19

isoproterenol

Back 19

increase hr
increase SBP,decrease DBP

Front 20

thigh

Back 20

太腿

Front 21

clotting factor

Back 21

凝固因子

Front 22

acetylsalicylic acid

Back 22

platelet aggregation

Front 23

dipyridamole

Back 23

platelet aggregation

Front 24

potentiating

Back 24

増強する

Front 25

warfarin inhibit

Back 25

epoxide reductase (VitK antagonist)

Front 26

selegiline

Back 26

inhibits the degradation of dopamine by MAO type B
inhibit MAO type B

Front 27

carbidopa

Back 27

inhibiting dopa decarboxylase

Front 28

bromocriptine&pergolide

Back 28

dopaminergic receptor agonist

Front 29

L-dopa

Back 29

precursor of dopamine

Front 30

precursor

Back 30

前駆体

Front 31

zileuton

Back 31

inhibit 5 lipoxygenase

Front 32

corticosteroid

Back 32

prevent relese of arachidonic acid

Front 33

beta2 agonist

Back 33

smooth muscle relaxation

Front 34

methylxanthines(theophylline)

Back 34

inhibit phosphodiesterase

Front 35

transient

Back 35

一過性の

Front 36

ophthalmologist

Back 36

眼科

Front 37

drowsiness

Back 37

眠気

Front 38

tingling

Back 38

うずき

Front 39

hyperchloremic

Back 39

高塩素性

Front 40

acetazolamide side effect

Back 40

parasthesia,drowsiness,hyperchloremic metabolic acidosis

Front 41

glaucoma

Back 41

緑内障

Front 42

laxative

Back 42

下剤

Front 43

endothelium

Back 43

内皮

Front 44

metaproterenol

Back 44

nonselective beta agonist cause vasodilation by activating beta2 receptor

Front 45

metaproterenol

Back 45

beta agonist

Front 46

muscle contraction

Back 46

収縮

Front 47

Tinnitus

Back 47

耳鳴り

Front 48

alopecia

Back 48

脱毛

Front 49

heparin binds to

Back 49

antithrombin3

Front 50

blurred

Back 50

ぼんやりとした

Front 51

cinchonism

Back 51

キニーネ中毒

Front 52

amenorrhea

Back 52

無月経

Front 53

oocytes

Back 53

卵母細胞

Front 54

euphoric

Back 54

陶酔させる化学物質

Front 55

euphoria is mediated by

Back 55

mu opioid receptor

Front 56

meperidine is a

Back 56

full mu agonist

Front 57

polydipsia

Back 57

多渇症

Front 58

oocytes

Back 58

卵母細胞

Front 59

euphoric

Back 59

陶酔させる化学物質

Front 60

euphoria is mediated by

Back 60

mu opioid receptor

Front 61

meperidine is a

Back 61

full mu agonist

Front 62

polydipsia

Back 62

多渇症

Front 63

metopronlol

Back 63

beta1 antagonist

Front 64

propranolol

Back 64

nonselective beta antagonist

Front 65

timolol

Back 65

nonselective beta antagonist

Front 66

diuretic

Back 66

利尿剤

Front 67

urination

Back 67

排尿

Front 68

prostatic

Back 68

前立腺の

Front 69

hyperplasia

Back 69

過形成

Front 70

finasteride

Back 70

inhibitor of 5-alpha-reductase,prevent the conversion of testosterone to dihydroteststerone

Front 71

steady state

Back 71

4,5times t1/2

Front 72

diplopia

Back 72

複視

Front 73

gingival hyperplasia

Back 73

歯肉過形成

Front 74

fetus

Back 74

胎児

Front 75

breech presentation

Back 75

骨盤位

Front 76

cephalic

Back 76

頭部の

Front 77

What are exceptions to PER? (6)

Back 77

[1] using earlier agreement to explain the final writing;

[2] Using earlier agreement to establish a Δ (e.g., fraud, duress, mistake, etc.);

[3] Using the earlier agreement to show that the written K would not become effective until a condition occurred (condition precedent);

[4] using earlier agreements to add to the final writing if the court concludes that the final writing was not intended as the complete agreement (the agreement in only partially integrated) – you can add but you can’t contradict.

[5] Collateral agreements are admissible;

[6] Oral or written agreements after the final writing

Front 78

ritdorine is

Back 78

beta2 agonist
uterine relaxation

Front 79

dantrolen

Back 79

prevents release of ca from the sarcoplasmic reticulum

Front 80

pralidoxime

Back 80

PAM:AChE reactivating agent

Front 81

ingest

Back 81

摂取する

Front 82

termini

Back 82

cheese,wine
broke down monoamine oxidase
cause release of norepinephrine

Front 83

goat drug1,2

Back 83

colchicine,allopurinol

Front 84

nadolol

Back 84

nonselective beta2 blocker

Front 85

atenolol

Back 85

cardioselective beta1 blocker

Front 86

esmolol

Back 86

cardioselective beta1 blocker

Front 87

metoprolol

Back 87

cardioselective beta1 blocker